Warning Issued on the Dangers of Vaping in Iowa

Dec.06.2022
Warning Issued on the Dangers of Vaping in Iowa
Local health experts in Cedar Falls, Iowa issue warning about the dangers of e-cigarettes and vaping.

Local health experts in Sioux City, Iowa are warning about the potential dangers of electronic cigarettes and vaping.


Electronic cigarettes containing nicotine and the cartridges in them are easily addictive, despite many people believing they are less harmful than traditional cigarettes. Doctors warn that electronic cigarettes are not subject to any safety regulations from health agencies, which does not mean they do not pose a significant threat to overall health.


Vaping was initially thought to be a safe substitute for smoking, but we gradually discovered that it is not," said Dr. David Ensz.


Doctors say that the likelihood of developing respiratory illnesses such as pneumonia is higher in people who use electronic cigarettes. Similar to regular cigarettes, electronic cigarettes still contain toxic substances.


Dr. Ensz says that electronic pod devices contain toxic chemicals, including one substance they are currently researching, which is Vitamin E. When heated and inhaled into the lungs, it can cause inflammation and harm.


If you are struggling to quit smoking, please reach out to your doctor who can help you create a personalized plan that you can stick to.


2FIRSTS will continue to provide ongoing coverage of this topic, with further updates available on the '2FIRSTSAPP'. Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Inter Tabac 2025: 2Firsts Provides Exclusive Coverage of New Tobacco Products and Industry Trends
Inter Tabac 2025: 2Firsts Provides Exclusive Coverage of New Tobacco Products and Industry Trends
2Firsts provides exclusive coverage of Inter Tabac 2025, capturing new tobacco products and industry trends for readers.
Sep.18 by 2FIRSTS.ai
Heaven Gifts’s HNB Brand REJO Launches New Device with Design Strikingly Similar to ELFBAR JOINOne Series
Heaven Gifts’s HNB Brand REJO Launches New Device with Design Strikingly Similar to ELFBAR JOINOne Series
Miracle’s heated tobacco brand REJO has launched its new device REJO CUBE in Dubai. The device’s industrial design is highly similar to the ELFBAR JOINOne series, featuring a left-right magnetic structure and side-mounted screen. Positioning the Middle East as a key market, REJO is moving ahead with local team building and entity setup in the region.
Nov.14 by 2FIRSTS.ai
2Firsts Observations | Two Months After Launch, BAT’s VELO Shift Draws Attention for Non-Traditional Design as Some Users Call for Higher Nicotine Strength
2Firsts Observations | Two Months After Launch, BAT’s VELO Shift Draws Attention for Non-Traditional Design as Some Users Call for Higher Nicotine Strength
British American Tobacco (BAT) introduced the VELO Shift nicotine pouch in September 2025, featuring a hexagonal outer can and an oval-triangle pouch shape that departs from traditional designs. Two months after launch, the product is available in the U.K., U.S. and Sweden. Social-media feedback indicates the design has been well received, while some users are calling for higher nicotine strength.
Nov.06 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
2Firsts On-Site at InterTabac: Industry Suppliers Confident About Outlook Despite Stagnant Cigarette Volumes
2Firsts On-Site at InterTabac: Industry Suppliers Confident About Outlook Despite Stagnant Cigarette Volumes
At InterTabac 2025, 2Firsts spoke with traditional tobacco suppliers. Despite stagnant cigarette sales in many regions, they remained optimistic, believing that adapting to market shifts could help them grow in a shrinking sector. Many companies are now moving into emerging categories like nicotine pouches, roll-your-own, and heat-not-burn products, using innovation and infrastructure upgrades to meet changing consumer and regulatory demands.
Sep.22
PMI Urges South Africa to Differentiate Smoke-Free Products from Cigarettes
PMI Urges South Africa to Differentiate Smoke-Free Products from Cigarettes
South Africa is drafting new tobacco legislation aimed at reducing smoking-related deaths and promoting harm reduction.PMI said smoke-free products such as nicotine pouches and heated devices could play a critical role in reducing harm. Patrik Hildingsson, PMI’s director for oral products communications, said South Africa is developing a new regulatory framework to recognise and regulate smoke-free products, calling it a “big change” for the industry.
Oct.22 by 2FIRSTS.ai